ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
6.43
-0.39 (-5.72%)
At close: Mar 28, 2025, 4:00 PM
6.31
-0.12 (-1.83%)
Pre-market: Mar 31, 2025, 5:08 AM EDT
ABIVAX Société Anonyme Stock Forecast
ABVX's stock price has decreased by -56.52% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ABIVAX Société Anonyme stock have an average target of 34.63, with a low estimate of 12 and a high estimate of 50. The average target predicts an increase of 438.57% from the current stock price of 6.43.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ABIVAX Société Anonyme stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 7 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Initiates $12 | Hold | Initiates | $12 | +86.63% | Mar 20, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $33 | Buy | Reiterates | $33 | +413.22% | Mar 18, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $33 | Buy | Reiterates | $33 | +413.22% | Jan 10, 2025 |
JMP Securities | JMP Securities | Buy Initiates $33 | Buy | Initiates | $33 | +413.22% | Dec 4, 2024 |
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +646.50% | Jul 29, 2024 |
Financial Forecast
Revenue This Year
50.86M
from 12.50M
Increased by 306.91%
Revenue Next Year
6.48M
from 50.86M
Decreased by -87.27%
EPS This Year
-2.43
EPS Next Year
-2.94
from -2.43
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 157.1M | 15.5M | 184.9M | ||
Avg | 50.9M | 6.5M | 109.6M | ||
Low | n/a | n/a | 62.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1,156.6% | -69.4% | 2,753.9% | ||
Avg | 306.9% | -87.3% | 1,592.0% | ||
Low | - | - | 860.2% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -1.49 | -1.41 |
Avg | -2.43 | -2.94 |
Low | -2.94 | -4.04 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.